User profiles for Harris Ioannidis

Harris Ioannidis

European Bioinformatics Institute | EMBL-EBI
Verified email at ebi.ac.uk
Cited by 201

The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods

…, S Corbett, M de Veij, H Ioannidis… - Nucleic acids …, 2024 - academic.oup.com
ChEMBL ( https://www.ebi.ac.uk/chembl/ ) is a manually curated, high-quality, large-scale,
open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like …

Alchemical free energy calculations and isothermal titration calorimetry measurements of aminoadamantanes bound to the closed state of influenza A/M2TM

H Ioannidis, A Drakopoulos, C Tzitzoglaki… - Journal of Chemical …, 2016 - ACS Publications
Adamantane derivatives, such as amantadine and rimantadine, have been reported to
block the transmembrane domain (TM) of the M2 protein of influenza A virus (A/M2) but their …

Interpreting thermodynamic profiles of aminoadamantane compounds inhibiting the M2 proton channel of influenza A by free energy calculations

N Homeyer, H Ioannidis, F Kolarov… - Journal of Chemical …, 2016 - ACS Publications
The development of novel anti-influenza drugs is of great importance because of the capability
of influenza viruses to occasionally cross interspecies barriers and to rapidly mutate. One …

[HTML][HTML] A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors

A De Simone, C Georgiou, H Ioannidis, AA Gupta… - Chemical …, 2019 - pubs.rsc.org
Cyclophilins (Cyps) are a major family of drug targets that are challenging to prosecute with
small molecules because the shallow nature and high degree of conservation of the active …

Resistance-mutation (N31) effects on drug orientation and channel hydration in amantadine-bound influenza A M2

ML Gleed, H Ioannidis, A Kolocouris… - The Journal of Physical …, 2015 - ACS Publications
The mechanism of amantadine binding to the S31 variant of the M2 protein of Influenza A is
well understood, but the reasons behind N31 M2 amantadine insensitivity remain under …

[HTML][HTML] Dynamic design: manipulation of millisecond timescale motions on the energy landscape of cyclophilin A

…, ASJS Mey, C Georgiou, H Ioannidis… - Chemical …, 2020 - pubs.rsc.org
Proteins need to interconvert between many conformations in order to function, many of
which are formed transiently, and sparsely populated. Particularly when the lifetimes of these …

Pushing the limits of detection of weak binding using fragment-based drug discovery: Identification of new cyclophilin binders

C Georgiou, I McNae, M Wear, H Ioannidis… - Journal of Molecular …, 2017 - Elsevier
Fragment-based drug discovery is an increasingly popular method to identify novel small-molecule
drug candidates. One of the limitations of the approach is the difficulty of accurately …

[PDF][PDF] Molecular Dynamics of Amantadine Block in M2 of Influenza A: WT VS S31N

ML Gleed, H Ioannidis, A Kolocouris, DD Busath - Biophysical Journal, 2015 - cell.com
The ability of amantadine to block wild-type influenza A M2 is profoundly influenced by its
position and orientation in the channel, which in turn affect the drug's hydration state, …

[PDF][PDF] Solid-State NMR Characterization of S31N M2 Transmembrane Domain Bound to Novel Adamantanes with Persistent In Vitro Efficacy

AK Wright, I Hung, C Tzitzoglaki, H Ioannidis… - Biophysical …, 2014 - cell.com
The M2 proton channel from Influenza A virus is essential for the viral lifecycle and is an
important drug target. Amino acid mutations in the residues lining the pore of the channel have …

[PDF][PDF] Influenza a Blockers with Reduced Resistance Formation

…, TA Cross, D Fedida, C Tzitzoglaki, H Ioannidis… - Biophysical …, 2014 - cell.com
432a Tuesday, February 18, 2014 adamantane cage reduced activity. Another showed that
the adduct must be more than 2 carbons. Pre-exposing the virus to drug before inoculation …